The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia

Yi Ying Wu, Tsu Yi Chao, Hsin Yi Liu, Tzu Chuan Huang, Jia Hong Chen, Ming Shen Dai, Anthony Janckila, Shiue Wei Lai, Ping Ying Chang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: The mechanism of cancer cachexia remains unclear and inflammatory cytokines may play a role in its development. Interleukin-6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor-a (TNFα) are known to be associated with cancer cachexia. Tartrate-resistant acid phos-phatase 5a (TRACP5α) is proposed to be related to chronic inflammation. In this study we hypothesize that TRACP5α is a chronic inflammatory marker that is correlated with cancer cachexia. Methods: Fifty-five cancer patients with and without cancer cachexia were enrolled from January 2009 to December 2012. Body mass index (BMI) was measured and serum total cholesterol, triglycerides and albumin were examined to evaluate the nutritional status. IL-6, CRP and TRACPSα protein activity were evaluated. Results: Inflammatory markers including IL-6, and CRP were significantly elevated in patients with cancer cachexia (ρ=0.0075 and 0.0021, respectively). Patients with cachexia also had higher CRP/albumin ratio (ρ =0.0265). TRACP5α activity, TRACP5α protein and their combinations with albumin were increased in the cancer cachexia groups but without significant difference. There were good correlations between IL-6, CRP, and BMI. Patients with higher TRACP5α activity had shorter survival (ρ=0.004). Conclusion:TRACP5α may be a promising chronic inflammatory marker and may play a prognostic role in cancer cachexia. Further large-scale prospective studies are warranted to confirm its role in the cancer cachexia process.

Original languageEnglish
Pages (from-to)325-331
Number of pages7
JournalJournal of B.U.ON.
Volume20
Issue number1
Publication statusPublished - Jan 1 2015

Fingerprint

Cachexia
C-Reactive Protein
Neoplasms
Acids
Interleukin-6
Albumins
Body Mass Index
Tartrate-Resistant Acid Phosphatase
Nutritional Status
tartaric acid
Triglycerides
Proteins
Tumor Necrosis Factor-alpha
Cholesterol
Prospective Studies
Cytokines
Inflammation
Survival

Keywords

  • Cancer cachexia
  • Chronic inflammation
  • Tartrate-resistant acid phosphatase 5a

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Hematology
  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

Wu, Y. Y., Chao, T. Y., Liu, H. Y., Huang, T. C., Chen, J. H., Dai, M. S., ... Chang, P. Y. (2015). The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia. Journal of B.U.ON., 20(1), 325-331.

The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia. / Wu, Yi Ying; Chao, Tsu Yi; Liu, Hsin Yi; Huang, Tzu Chuan; Chen, Jia Hong; Dai, Ming Shen; Janckila, Anthony; Lai, Shiue Wei; Chang, Ping Ying.

In: Journal of B.U.ON., Vol. 20, No. 1, 01.01.2015, p. 325-331.

Research output: Contribution to journalArticle

Wu, YY, Chao, TY, Liu, HY, Huang, TC, Chen, JH, Dai, MS, Janckila, A, Lai, SW & Chang, PY 2015, 'The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia', Journal of B.U.ON., vol. 20, no. 1, pp. 325-331.
Wu, Yi Ying ; Chao, Tsu Yi ; Liu, Hsin Yi ; Huang, Tzu Chuan ; Chen, Jia Hong ; Dai, Ming Shen ; Janckila, Anthony ; Lai, Shiue Wei ; Chang, Ping Ying. / The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia. In: Journal of B.U.ON. 2015 ; Vol. 20, No. 1. pp. 325-331.
@article{a60da86f444d451db5b22f967a5188bb,
title = "The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia",
abstract = "Purpose: The mechanism of cancer cachexia remains unclear and inflammatory cytokines may play a role in its development. Interleukin-6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor-a (TNFα) are known to be associated with cancer cachexia. Tartrate-resistant acid phos-phatase 5a (TRACP5α) is proposed to be related to chronic inflammation. In this study we hypothesize that TRACP5α is a chronic inflammatory marker that is correlated with cancer cachexia. Methods: Fifty-five cancer patients with and without cancer cachexia were enrolled from January 2009 to December 2012. Body mass index (BMI) was measured and serum total cholesterol, triglycerides and albumin were examined to evaluate the nutritional status. IL-6, CRP and TRACPSα protein activity were evaluated. Results: Inflammatory markers including IL-6, and CRP were significantly elevated in patients with cancer cachexia (ρ=0.0075 and 0.0021, respectively). Patients with cachexia also had higher CRP/albumin ratio (ρ =0.0265). TRACP5α activity, TRACP5α protein and their combinations with albumin were increased in the cancer cachexia groups but without significant difference. There were good correlations between IL-6, CRP, and BMI. Patients with higher TRACP5α activity had shorter survival (ρ=0.004). Conclusion:TRACP5α may be a promising chronic inflammatory marker and may play a prognostic role in cancer cachexia. Further large-scale prospective studies are warranted to confirm its role in the cancer cachexia process.",
keywords = "Cancer cachexia, Chronic inflammation, Tartrate-resistant acid phosphatase 5a",
author = "Wu, {Yi Ying} and Chao, {Tsu Yi} and Liu, {Hsin Yi} and Huang, {Tzu Chuan} and Chen, {Jia Hong} and Dai, {Ming Shen} and Anthony Janckila and Lai, {Shiue Wei} and Chang, {Ping Ying}",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "20",
pages = "325--331",
journal = "Journal of B.U.ON.",
issn = "1107-0625",
publisher = "Balkan Union of Oncology",
number = "1",

}

TY - JOUR

T1 - The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with cancer cachexia

AU - Wu, Yi Ying

AU - Chao, Tsu Yi

AU - Liu, Hsin Yi

AU - Huang, Tzu Chuan

AU - Chen, Jia Hong

AU - Dai, Ming Shen

AU - Janckila, Anthony

AU - Lai, Shiue Wei

AU - Chang, Ping Ying

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Purpose: The mechanism of cancer cachexia remains unclear and inflammatory cytokines may play a role in its development. Interleukin-6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor-a (TNFα) are known to be associated with cancer cachexia. Tartrate-resistant acid phos-phatase 5a (TRACP5α) is proposed to be related to chronic inflammation. In this study we hypothesize that TRACP5α is a chronic inflammatory marker that is correlated with cancer cachexia. Methods: Fifty-five cancer patients with and without cancer cachexia were enrolled from January 2009 to December 2012. Body mass index (BMI) was measured and serum total cholesterol, triglycerides and albumin were examined to evaluate the nutritional status. IL-6, CRP and TRACPSα protein activity were evaluated. Results: Inflammatory markers including IL-6, and CRP were significantly elevated in patients with cancer cachexia (ρ=0.0075 and 0.0021, respectively). Patients with cachexia also had higher CRP/albumin ratio (ρ =0.0265). TRACP5α activity, TRACP5α protein and their combinations with albumin were increased in the cancer cachexia groups but without significant difference. There were good correlations between IL-6, CRP, and BMI. Patients with higher TRACP5α activity had shorter survival (ρ=0.004). Conclusion:TRACP5α may be a promising chronic inflammatory marker and may play a prognostic role in cancer cachexia. Further large-scale prospective studies are warranted to confirm its role in the cancer cachexia process.

AB - Purpose: The mechanism of cancer cachexia remains unclear and inflammatory cytokines may play a role in its development. Interleukin-6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor-a (TNFα) are known to be associated with cancer cachexia. Tartrate-resistant acid phos-phatase 5a (TRACP5α) is proposed to be related to chronic inflammation. In this study we hypothesize that TRACP5α is a chronic inflammatory marker that is correlated with cancer cachexia. Methods: Fifty-five cancer patients with and without cancer cachexia were enrolled from January 2009 to December 2012. Body mass index (BMI) was measured and serum total cholesterol, triglycerides and albumin were examined to evaluate the nutritional status. IL-6, CRP and TRACPSα protein activity were evaluated. Results: Inflammatory markers including IL-6, and CRP were significantly elevated in patients with cancer cachexia (ρ=0.0075 and 0.0021, respectively). Patients with cachexia also had higher CRP/albumin ratio (ρ =0.0265). TRACP5α activity, TRACP5α protein and their combinations with albumin were increased in the cancer cachexia groups but without significant difference. There were good correlations between IL-6, CRP, and BMI. Patients with higher TRACP5α activity had shorter survival (ρ=0.004). Conclusion:TRACP5α may be a promising chronic inflammatory marker and may play a prognostic role in cancer cachexia. Further large-scale prospective studies are warranted to confirm its role in the cancer cachexia process.

KW - Cancer cachexia

KW - Chronic inflammation

KW - Tartrate-resistant acid phosphatase 5a

UR - http://www.scopus.com/inward/record.url?scp=84928695643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928695643&partnerID=8YFLogxK

M3 - Article

C2 - 25778334

AN - SCOPUS:84928695643

VL - 20

SP - 325

EP - 331

JO - Journal of B.U.ON.

JF - Journal of B.U.ON.

SN - 1107-0625

IS - 1

ER -